Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
9,151.18
8,171.16
7,081.55
6,559.10
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
9,151.18
8,171.16
7,081.55
6,559.10
Raw Material Cost
2,055.74
1,976.83
1,682.46
1,566.96
Purchase of Finished goods
1,417.32
1,175.77
952.20
829.07
(Increase) / Decrease In Stocks
-241.41
-198.60
68.64
55.21
Employee Cost
2,307.47
2,029.50
1,896.35
1,588.83
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
2,167.23
1,991.40
1,853.66
1,569.37
Total Expenditure (Excl Depreciation)
7,706.35
6,974.90
6,453.31
5,609.44
Operating Profit (PBDIT) excl Other Income
1,444.83
1,196.26
628.24
949.66
Other Income
134.81
175.39
225.11
275.80
Operating Profit (PBDIT)
1,579.64
1,371.65
853.35
1,225.46
Interest
421.59
448.49
344.18
198.25
Exceptional Items
0.00
-62.79
-6.96
-15.08
Gross Profit (PBDT)
1,158.05
860.37
502.21
1,012.13
Depreciation
816.34
740.57
676.69
586.18
Profit Before Tax
341.71
119.80
-174.48
425.95
Tax
323.51
161.47
66.31
109.02
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
18.20
-41.67
-240.79
316.93
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
18.20
-41.67
-240.79
316.93
Share in Profit of Associates
72.93
59.49
54.33
59.03
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
91.13
17.82
-186.46
375.96
Equity Capital
1,324.35
1,322.95
1,193.32
1,185.91
Face Value
10.0
10.0
10.0
10.0
Reserves
6,801.12
6,588.42
5,580.18
5,510.69
Earnings per share (EPS)
0.69
0.13
-1.56
3.1
Diluted Earnings per share
0.68
0.14
-1.57
3.19
Operating Profit Margin (Excl OI)
15.79%
14.64%
8.87%
14.48%
Gross Profit Margin
12.65%
10.53%
7.09%
15.43%
PAT Margin
1.0%
0.22%
-2.63%
5.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 11.99% vs 15.39% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 411.39% vs 109.56% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 20.78% vs 90.41% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -6.00% vs 30.31% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Piramal Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
9,151.18
7,896.00
1,255.18
15.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,151.18
7,896.00
1,255.18
15.90%
Raw Material Cost
2,055.74
1,526.90
528.84
34.63%
Purchase of Finished goods
1,417.32
1,883.24
-465.92
-24.74%
(Increase) / Decrease In Stocks
-241.41
-263.53
22.12
8.39%
Employee Cost
2,307.47
1,446.29
861.18
59.54%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2,167.23
1,828.73
338.50
18.51%
Total Expenditure (Excl Depreciation)
7,706.35
6,421.62
1,284.73
20.01%
Operating Profit (PBDIT) excl Other Income
1,444.83
1,474.38
-29.55
-2.00%
Other Income
134.81
67.26
67.55
100.43%
Operating Profit (PBDIT)
1,579.64
1,541.64
38.00
2.46%
Interest
421.59
175.78
245.81
139.84%
Exceptional Items
0.00
-10.38
10.38
100.00%
Gross Profit (PBDT)
1,158.05
1,355.48
-197.43
-14.57%
Depreciation
816.34
384.13
432.21
112.52%
Profit Before Tax
341.71
971.35
-629.64
-64.82%
Tax
323.51
263.88
59.63
22.60%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
18.20
707.47
-689.27
-97.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
18.20
707.47
-689.27
-97.43%
Share in Profit of Associates
72.93
0.00
72.93
Minority Interest
0.00
-26.14
26.14
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
91.13
681.33
-590.20
-86.62%
Equity Capital
1,324.35
189.48
1,134.87
598.94%
Face Value
10.00
10.00
0.00
Reserves
6,801.12
4,256.70
2,544.42
59.77%
Earnings per share (EPS)
0.69
35.96
-35.27
-98.08%
Diluted Earnings per share
0.68
36.43
-35.75
-98.13%
Operating Profit Margin (Excl OI)
15.79%
18.67%
0.00
-2.88%
Gross Profit Margin
12.65%
17.17%
0.00
-4.52%
PAT Margin
1.00%
8.96%
0.00
-7.96%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 9,151.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.99% vs 15.39% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 91.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 411.39% vs 109.56% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,444.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.78% vs 90.41% in Mar 2024
Annual - Interest
Interest 421.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.00% vs 30.31% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.79%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
